Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 20834 | $0.00 - $0.00 | $0 |
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 8851 | $11.89 - $11.89 | $105,238 |
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 2812 | $0.00 - $0.00 | $0 |
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 1427 | $11.89 - $11.89 | $16,967 |
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
M | Common Stock | A | 2812 | $0.00 - $0.00 | $0 |
| 2024-04-15 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
F | Common Stock | D | 1427 | $11.89 - $11.89 | $16,967 |
| 2024-03-04 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 15623 | $0.00 - $0.00 | $0 |
| 2024-03-04 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 8053 | $16.96 - $16.96 | $136,578 |
| 2024-03-04 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 41662 | $0.00 - $0.00 | $0 |
| 2024-03-04 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 11449 | $16.96 - $16.96 | $194,175 |
| 2024-02-20 | IOVANCE BIOTHERAPEUTICS, INC. | MCPEAK MERRILL A
(Director) |
P | Common Stock | A | 250000 | $9.15 - $9.15 | $2,287,500 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
M | Common Stock | A | 20834 | $0.00 - $0.00 | $0 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | Vogt Frederick G
(Interim CEO & General Counsel) |
F | Common Stock | D | 6530 | $8.37 - $8.37 | $54,656 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | GRAF FINCKENSTEIN...
(Chief Medical Officer) |
F | Common Stock | D | 1577 | $8.37 - $8.37 | $13,199 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
M | Common Stock | A | 2813 | $0.00 - $0.00 | $0 |
| 2024-01-16 | IOVANCE BIOTHERAPEUTICS, INC. | BILINSKY IGOR
(Chief Operating Officer) |
F | Common Stock | D | 1577 | $8.37 - $8.37 | $13,199 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |